Xin Jiang

Xin Jiang has a strong background in the biopharmaceutical industry with experience in various leadership roles. Xin co-founded Protego Biopharma in 2017 and served as the Startup CEO until 2021. In this role, they contributed to the company's growth and success. Additionally, Xin worked at Polaris Pharmaceuticals as the Director of Biology from 2011 to 2016. Prior to that, they gained valuable experience as a Senior Principal Scientist at Pfizer from 2001 to 2010. Xin's career started at The Scripps Research Institute, where they worked as a Postdoc from 1999 to 2001. Their expertise and experience make him a valuable asset in the biopharmaceutical industry.

Xin Jiang attended Rutgers University, where they pursued a Ph.D. in Protein Biophysics and Computational Biology. Their education at this institution included in-depth study and research in these fields. Prior to their time at Rutgers, Xin Jiang obtained a Bachelor of Science degree from Wuhan University. The specific field of study for their undergraduate degree is not provided.